For the quarter ending 2026-03-31, XGN had -$10,707K decrease in cash & cash equivalents over the period. -$10,645K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -3,967 | -4,673 | -7,087 | -8,191 |
| Depreciation and amortization | 599 | 600 | 612 | 906 |
| Amortization of debt discount and debt issuance costs | 133 | 131 | 126 | 121 |
| Loss on extinguishment of debt | - | 0 | 0 | -295 |
| Amortization of loan commitment fees | 661 | 277 | 277 | 184 |
| Change in fair value of warrant liability | -882 | -1,602 | 2,670 | 438 |
| Non-cash operating lease expense | 256 | 250 | 717 | - |
| Stock-based compensation | 655 | 705 | 593 | 860 |
| Bad debt expense | - | - | - | 455 |
| Non-cash interest expense | - | - | - | 68 |
| Other | 99 | 0 | -69 | -78 |
| Non-cash lease expense | - | - | - | 473 |
| Accounts receivable, net | 4,918 | -237 | -3,635 | 6,892 |
| Prepaid expenses and other current assets | 1,140 | 250 | -560 | -798 |
| Other assets | -172 | -298 | -206 | -288 |
| Operating lease liabilities | -295 | -288 | -275 | -533 |
| Accounts payable | -41 | 587 | 1,032 | -1,577 |
| Deferred revenue | 6 | 34 | -375 | 283 |
| Accrued and other current liabilities | -1,557 | 681 | 1,180 | -1,610 |
| Net cash used in operating activities | -10,417 | -3,013 | 2,944 | -13,556 |
| Purchases of property and equipment | 228 | 44 | 275 | 322 |
| Proceeds from disposal of property and equipment | 0 | 9 | 0 | 6 |
| Net cash used in investing activities | -228 | -35 | -275 | -316 |
| Proceeds from common stock issued in public offering, net of issuance costs | - | 0 | 18,627 | - |
| Proceeds from common stock issued under atm, net of issuance costs | - | -38 | -15,341 | 18,777 |
| Proceeds from issuance of debt and warrants, net of discounts | - | 0 | 0 | 23,672 |
| Proceeds from common stock issued under employee stock purchase plan | 295 | 0 | 199 | 199 |
| Payment to extinguish debt | - | 0 | 0 | 19,705 |
| Proceeds from exercise of stock options | - | 0 | 0 | - |
| Principal payments on finance lease obligations | 189 | 181 | 174 | 139 |
| Principal payments on notes payable obligations | 168 | 165 | 162 | 265 |
| Payment of debt issuance costs | 0 | 0 | 199 | 670 |
| Net cash used in financing activities | -62 | -384 | 2,950 | 21,869 |
| Net decrease in cash, cash equivalents and restricted cash | -10,707 | -3,432 | 5,619 | 7,997 |
| Cash, cash equivalents and restricted cash, beginning of period | 32,420 | 35,852 | 22,236 | - |
| Cash, cash equivalents and restricted cash, end of period | 21,713 | 32,420 | 35,852 | - |
EXAGEN INC. (XGN)
EXAGEN INC. (XGN)